Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates.
Ignacio Relaño-Rodríguez, Jianqiu Du, Zi Jie Lin, Margaret Kerwin, Marta Tarquis-Medina, Eduardo Urbano, Jiayan Cui, Meagan Watkins, Peng Zhao, Rumi Habib, Sukanya Ghosh, Joyce H. Park, Caroline Boroughs, Agnes A. Walsh, Mariane B. Melo, , Amelia Escolano
This paper introduces WIN332, an engineered immunogen that elicits N332-glycan-independent V3-glycan antibodies in nonhuman primates after a single immunization.
bioRxiv · Sep 4, 2025 · PreprintImmunology